Differential response to genotoxic stress in immortalized or transformed human T-lymphotropic virus type I-infected T-cells

Journal of General Virology

Volumn 80, Issue 7, 1999, Pages 1575-1581

  Cereseto, Anna ^a   Kislyakova, Tatiana ^a,b   Parks, Robyn Washington ^a   Nicot, Christophe ^a   Franchini, Genoveffa ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b INSTITUTE OF CYTOLOGY   (Russian Federation)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR; PROTEIN BCL 2; PROTEIN BCL X; PROTEIN P21; PROTEIN P53;

APOPTOSIS; ARTICLE; CELL IMMORTALIZATION; GENOTOXICITY; HUMAN; HUMAN CELL; HUMAN T CELL LEUKEMIA VIRUS 1; PRIORITY JOURNAL; VIRUS CELL TRANSFORMATION;

HTLV; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN T-LYMPHOTROPIC VIRUS 1; RNA VIRUSES;

EID: 0033038176     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/0022-1317-80-7-1575     Document Type: Article

References (38)

1. Akagi, T. & Shimotohno, K. (1993). Proliferative response of Tax1-transduced primary human T-cells to anti-CD3 antibody stimulation by an interleukin-2-independent pathway. Journal of Virology 67, 1211-1217.
2. Akagi, T., Ono, H., Tsuchida, N. & Shimotohno, K. (1997). Aberrant expression and function of p53 in T-cells immortalized by HTLV-I Tax 1. FEBS Letters 406, 263-266.
3. Boise, L. H., Minn, A. J., June, C. H., Lindsten, T. & Thompson, C. B. (1995). Growth factors can enhance lymphocyte survival without committing the cell to undergo cell division. Proceedings of the National Academy of Sciences, USA 92, 5491-5495.
4. waf1/cip1 human T-cell lymphotropic/leukemia virus type (HTLV-I) transformed T-cell. Blood 88, 1551-1560.
5. KIP1 correlates with constitutive activation of cyclin E-CDK2 complex in HTLV-I-transformed T-cells. Oncogene (in press).
6. Collins, M., Marvel, J., Malde, P. & Lopez-Rivas, A. (1992). Interleukin 3 protects murine bone marrow cells from apoptosis induced by DNA damaging agents. Journal of Experimental Medicine 176, 1043-1051.
7. De Rossi, A., Aldovini, A., Franchini, G., Mann, D., Gallo, R. C. & Wong-Staal, F. (1985). Clonal selection of T lymphocytes infected by cell-free human T-cell leukemia/lymphoma virus type 1: parameters of virus integration and expression. Virology 143, 640-645.
8. Firpo, E. J., Koff, A., Solomon, M. J. & Roberts, J. M. (1994). Inactivation of a Cdk2 inhibitor during interleukin 2-induced proliferation of human T lymphocytes. Molecular and Cellular Biology 14, 4889-4901.
9. Franchini, G. (1995). Molecular mechanisms of human T-cell leukemia/lymphotropic virus type I infection. Blood 86, 3619-3639.
10. Franchini, G., Mann, D. L., Popovic, M., Zicht, R. R., Gallo, R. C. & Wong-Staal, F. (1985). HTLV-I infection of T and B cells of a patient with adult T-cell leukemia-lymphoma (ATLL) and transmission of HTLV-I from B cells to normal T-cells. Leukemia Research 9, 1305-1314.
11. Franchini, G., Cereseto, A., Tryniszewska, E., Rivadeneira, E., Kislyakova, T., Mulloy, J. C., Takemoto, S., Casareto, L., Nicot, C. & Trovato, R. (1999). Telomerase activation, rearrangement, and inhibition of cell-cycle inhibitors in human T-cells immortalized or transformed by HTLV-I. In HTLV-I Pathogenesis. Charlottesville: University of Virginia Press.
12. Gallo, R. C. (1986). The first human retrovirus. Scientific American 255, 88-98.
13. Grassman, R., Dengler, C., Muller-Fleckenstein, I., Fleckenstein, B., McGuire, K., Dokhelar, M. C., Sodroski, J. G. & Haseltine, W. A. (1989). Transformation to continuous growth of primary human T-lymphocytes by human T-cell leukemia virus type I X-region genes transduced by herpesvirus saimiri vector. Proceedings of the National Academy of Sciences, USA 86, 3351-3355.
14. Hahn, B., Gallo, R. C., Franchini, G., Popovic, M., Aoki, T., Salahuddin, S. Z., Markham, P. D. & Wong-Staal, F. (1984). Clonal selection of human T-cell leukemia virus-infected cells in vivo and in vitro. Molecular Biology and Medicine 2, 29-36.
15. Hinuma, Y., Nagata, K., Hanaoka, M., Nakai, M., Matsumoto, T., Kinoshita, K. I., Shirakawa, S. & Miyoshi, I. (1981). Adult T-cell leukemia antigen in an ATL cell line and detection of antibodies to the antigen in human sera. Proceedings of the National Academy of Sciences, USA 78, 6476-6480.
16. Jin, D.-Y., Spencer, F. & Jeang, K.-T. (1998). Human T-cell leukemia virus type 1 oncoprotein Tax targets the human mitotic checkpoint protein MAD1. Cell 93, 1-20.
17. kip1 mediates apoptosis in endothelial cells through activation of cdk2: role of a caspase cascade. Molecular Cell 1, 553-563.
18. Low, K. G., Dorner, L. F., Fernando, D. B., Grossman, J., Jeang, K.-T. & Comb, M. J. (1997). Human T-cell leukemia virus type 1 tax releases cell cycle arrest induced by p16INK4a. Journal of Virology 71, 1956-1962.
19. Markham, P. D., Salahuddin, S. Z., Kalyanaraman, V. S., Popovic, M., Sarin, P. & Gallo, R. C. (1983). Infection and transformation of fresh human umbilical cord blood cells by multiple sources of human T-cell leukemia-lymphoma virus (HTLV). International Journal of Cancer 31, 413-420.
20. Migone, T. S., Lin, J. X., Cereseto, A., Mulloy, J. C., O'Shea, J. J., Franchini, G. & Leonard, W. J. (1995). Constitutively activated JAK-STAT pathway in T-cells transformed with HTLV-I. Science 269, 79-81.
21. Migone, T. S., Cacalano, N. A., Taylor, N., Yi, T., Waldmann, T. A. & Johnston, J. A. (1998). Recruitment of SH2-containing protein tyrosine phosphatase SHP-1 to the interleukin 2 receptor; loss of SHP-1 expression in human T-lymphotropic virus type I-transformed T cells. Proceedings of the National Academy of Sciences, USA 95, 3845-3850.
22. Miyoshi, I., Kubonishi, I., Yoshimoto, S., Akagi, T., Ohtsuki, Y., Shiraishi, Y., Nagata, K. & Hinuma, Y. (1981). Type C virus particles in a cord T-cell line derived by co-cultivating normal human cord leukocytes and human leukaemic T-cells. Nature 294, 770-771.
23. Mor, F. & Cohen, I. R. (1996). IL-2 rescues antigen-specific T cells from radiation or dexamethasone-induced apoptosis. Correlation with induction of bcl-2. Journal of Immunology 156, 515-522.
24. Mulloy, J. C., Kislyakova, T., Cereseto, A., Casareto, L., Lo Monico, A., Fullen, J., Lorenzi, M. V., Cara, A., Nicot, C., Giam, C.-Z. & Franchini, G. (1998). Human T-cell lymphotropic/leukemia virus type 1 Tax abrogates p53-induced cell cycle arrest and apoptosis through its CREB/ATL functional domain. Journal of Virology 72, 8852-8860.
25. Murphy, E. L., Hanchard, B., Figueroa, J. P., Gibbs, W. N., Lofters, W. S., Campbell, M., Goedert, J. J. & Blattner, W. A. (1989). Modeling the risk of adult T-cell leukemia/lymphoma in persons infected with human T-lymphotropic virus type I. International Journal of Cancer 43, 250-253.
26. kip1 cyclin-dependent kinase inhibitor prevented by rapamycin. Nature 372, 570-573.
27. Patchen, M. L., MacVittie, T. J., Williams, J. L., Schwartz, G. N. & Souza, L. M. (1991). Administration of interleukin-6 stimulates multi-lineage hematopoiesis and accelerates recovery from radiation-induced hematopoietic depression. Blood 77, 472-480.
28. Pise-Masison, C. A., Choi, K.-S., Radonovich, M., Dittmer, J., Kim, S.-J. & Brady, J. N. (1998 a). Inhibition of p53 transactivation function by the human T-cell lymphotropic virus type 1 Tax protein. Journal of Virology 72, 1165-1170.
29. Pise-Masison, C. A., Radonovich, M., Sakaguchi, K., Appella, E. & Brady, J. N. (1998 b). Phosphorylation of p53: a novel pathway for p53 inactivation in human T-cell lymphotropic virus type 1-transformed cells. Journal of Virology 72, 6348-6355.
30. Poiesz, B. J., Ruscetti, F. W., Gazdar, A. F., Bunn, P. A., Minna, J. D. & Gallo, R. C. (1980). Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proceedings of the National Academy of Sciences, USA 77, 7415-7419.
31. Popovic, M., Lange-Wantzin, G., Sarin, P. S., Mann, D. & Gallo, R. C. (1983). Transformation of human umbilical cord blood T-cells by human T-cell leukemia/lymphoma virus. Proceedings of the National Academy of Sciences, USA 80, 5402-5406.
32. Sachs, L. & Lotem, J. (1993). Control of programmed cell death in normal and leukemic cells : new implications for therapy. Blood 82, 15-21.
33. Seki, H., Iwai, K., Kanegane, H., Konno, A., Ohta, K., Ohta, K., Yachie, A., Taniguchi, N. & Miyawaki, T. (1995). Differential protective action of cytokines on radiation-induced apoptosis of peripheral lymphocyte subpopulation. Cellular Immunology 163, 30-36.
34. Sherr, C. J. & Roberts, J. M. (1995). Inhibitors of mammalian G1 cyclin-dependent kinases. Genes and Development 9, 1149-1163.
35. Suzuki, T., Kitao, S., Matsushime, H. & Yoshida, M. (1996). HTLV-1 Tax protein interacts with cyclin-dependent kinase inhibitor p16INK4A and counteracts its inhibitory activity towards CDK4. European Molecular Biology Organization Journal 15, 1607-1614.
36. Takemoto, S., Mulloy, J. C., Cereseto, A., Migone, T. S., Patel, B. K. R., Matsuoka, M., Yamaguchi, K., Takatsuki, K., Kamihira, S., White, J. D., Leonard, W. J., Waldmann, T. & Franchini, G. (1997). Proliferation of adult T-cell leukemia/lymphoma cells is associated with the constitutive activation of JAK/STAT proteins. Proceedings of the National Academy of Sciences, USA 94, 13897-13902.
37. Wattel, E., Vartanian, J. P., Pannetier, C. & Wain-Hobson, S. (1995). Clonal expansion of human T-cell leukemia virus type I-infected cells in asymptomatic and symptomatic carriers without malignancy. Journal of Virology 69, 2863-2868.
38. Xu, X., Kang, S. H., Heidenreich, O., Okerholm, M., O'Shea, J. J. & Nerenberg, M. I. (1995). Constitutive activation of different Jak tyrosine kinases in human T-cell leukemia virus type 1 (HTLV-1) tax protein or virus-transformed cells. Journal of Clinical Investigation 96, 1548-1555.